# Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease

> **NCT06478134** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Seville** · enrollment: 124 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Trimix tear substitutes
- **DRUG:** Hyaluronic acid tear substitute

## Key facts

- **NCT ID:** NCT06478134
- **Lead sponsor:** University of Seville
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2024-01-10
- **Final completion:** 2024-05-01
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2024-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478134, "Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06478134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*